An initial trial of Revascor last year in 60 American patients with congestive heart failure saw a 75 per cent reduction in the risk of related deaths over the following 21 months.
Revascor的首次尝试，是在去年60例患有充血性心力衰竭的美国病人，在接下来的21个月里，检查证明相关的死亡风险下降了75%。
Design, Setting, and patients Multicenter, randomized controlled trial among 2331 medically stable outpatients with heart failure with left ventricular ejection fraction of 35% or less.
试验设计、设定与病人多中心随机对照试验，2331名医学上稳定的门诊心衰患者，左心室射血分数小于等于35%。
Current research interests include clinical trial design, and the pathophysiology and treatment of heart failure in companion animals.
现在研究的项目包括临床试验设计和伴侣动物心衰的病理生理学和治疗。
Coenzyme Q10 decreases all cause mortality byhalf, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress.
根据今天在心衰2013会议上公布的多中心随机双盲实验的结果，辅酶Q10减低一半所有原因的死亡率。
We conducted a multicenter, double-blind, placebo-controlled trial involving patients hospitalized for acute heart failure with impaired renal function.
对急性心力衰竭伴肾功能受损的住院患者进行多中心、双盲安慰剂对照试验。
Methods In a randomized trial, we compared ICD therapy or amiodarone with state-of-the-art medical therapy alone in 2521 patients who had stable heart failure with depressed left ventricular function.
方法：在随机研究中，我们纳入了2521例稳定性左心功能不全的心力衰竭患者，比较ICD治疗、胺碘酮治疗或单用优化药物治疗对生命质量的影响。
It has been reported that myoblast transplantation for heart failure after myocardial infarction succeeded in clinical trial.
其中成肌细胞移植用来改善心肌梗死后的心脏功能，已有临床报道，并取得成功。
Methods A total of 106 DCM patients with heart failure were allotted into trial group and control group at random.
方法将106例患者随机分为两组，在常规抗心力衰竭基础上，渝疗组加用二丁酰环磷腺苷钙静脉给药；
The trial followed 2,331 stable heart failure patients from the United States, Canada and France.
该实验跟踪了美国、加拿大和法国的2331例稳定的心衰患者。
The trial followed 2,331 stable heart failure patients from the United States, Canada and France.
该实验跟踪了美国、加拿大和法国的2331例稳定的心衰患者。
应用推荐